OFIX - Orthofix Medical Inc.
IEX Last Trade
17.45
0.120 0.688%
Share volume: 1,639
Last Updated: Fri 27 Dec 2024 08:29:49 PM CET
Surgical and Medical Instrument Manufacturing :
-0.06%
PREVIOUS CLOSE
CHG
CHG%
$17.33
0.12
0.69%
Fundamental analysis
4%
Profitability
0%
Dept financing
15%
Liquidity
23%
Performance
0%
Performance
5 Days
2.89%
1 Month
-6.80%
3 Months
16.38%
6 Months
32.27%
1 Year
28.92%
2 Year
-7.47%
Key data
Stock price
$17.45
DAY RANGE
$17.14 - $17.80
52 WEEK RANGE
$12.45 - $20.73
52 WEEK CHANGE
$32.27
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/06/2024
Company detail
CEO: Jon C. Serbousek
Region: US
Website: orthofix.com
Employees: 1,090
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing
Region: US
Website: orthofix.com
Employees: 1,090
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing
Orthofix Medical Inc. operates as a medical device and biologics company in the United States, Italy, Germany, France, the United Kingdom, Brazil, and internationally. The Global Spine segment manufactures, distributes, and provides support services for bone growth stimulator devices that enhance bone fusion, as well as used as a therapeutic treatment for non-spinal and appendicular fractures. This segment designs, develops, and markets orthopedic products that are used in fracture repair, deformity correction, and bone reconstruction procedures.
Recent news